Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gse1 coiled-coil protein (GSE1) is a proline-rich protein containing coiled-coil domains, encoded by the GSE1 gene. It is thought to act as a subunit of the BRAF35-HDAC (BHC) histone deacetylase complex, thereby potentially regulating chromatin remodeling and gene transcription. Evidence suggests that GSE1 may function as an oncogene in breast cancer and its expression is elevated in some breast cancer patients. Disease associations include intraventricular meningioma, myoclonic cerebellar dyssynergia, and, from ortholog data, stomach cancer. While its precise molecular functions are not fully elucidated, GSE1 is not currently recognized as a direct receptor, enzyme, transporter, or established drug target in therapeutic settings
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gse1 coiled-coil protein (GSE1).